Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of ascending multiple oral doses of SAM-531, an
investigational drug, in healthy Japanese young male and elderly subjects.To provide the
pharmacokinetics (PK) and pharmacodynamics (PD) profiles of multiple oral doses of SAM-531 in
healthy Japanese young male and elderly subjects.